Henry Schein, Inc. (HSIC)

Arrowstreet Capital Limited Partnership grew its stake in Henry Schein, Inc. (NASDAQ: HSIC) by 80.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Excha...

Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong market share. HSIC continues to deliver soli...

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?...

Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript...

Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound....

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the dril...

HSIC gains momentum as Henry Schein One rolls out AI-powered dental workflows unveiled at the Greater New York Dental Meeting....

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung...

AMERICAN FORK, Utah--(BUSINESS WIRE)--Coming off the heels of its announcement with Amazon Web Services, Henry Schein One, the leading provider of global dental technology, today unveils natively embe...

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. Shares of Henry Schein declined as p...